PTC Therapeutics
PTCT
63.23
-0.47
-0.74%
PTC Therapeutics
US · PTCT
#2071 by market cap
Listed 1970
63.23
-0.47
-0.74%
Live - 5344 symbols - heartbeat 431s ago
· 2026-10-08 08:05
Pre-market
63.62
+0.62%
After-hours
63.23
0.00%
- Market cap
- 5.28B
- P/E (TTM)i
- -103.66
- P/Bi
- -31.92
- EPSi
- 7.78
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on PTCT?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 10 analysts
Buy
Avg price target
100.20 +58.5%
Price target rangecurrent 63.23
Low70.00
Avg100.20
High137.00
Buy 80%
Hold 10%
Sell 10%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-21 | Cantor Fitzgerald | -- | BUY | 137.00 |
| 2026-09-14 | Leerink Partners | -- | BUY | 98.00 |
| 2026-09-02 | Wells Fargo | -- | BUY | 109.00 |
| 2026-08-30 | TD Cowen | -- | BUY | 90.00 |
| 2026-08-13 | Wells Fargo | -- | BUY | 109.00 |
| 2026-08-13 | BofA Securities | -- | BUY | 96.00 |
| 2026-08-13 | Barclays | -- | BUY | 122.00 |
| 2026-08-12 | Cantor Fitzgerald | -- | BUY | 130.00 |
| 2026-08-03 | Barclays | -- | BUY | 120.00 |
| 2026-07-31 | Wells Fargo | -- | BUY | 106.00 |
| 2026-07-31 | Morgan Stanley | -- | BUY | 104.00 |
| 2026-07-30 | TD Cowen | -- | BUY | 90.00 |
| 2026-07-30 | Cantor Fitzgerald | -- | BUY | 130.00 |
| 2026-07-30 | Wells Fargo | -- | BUY | 106.00 |
| 2026-07-30 | BofA Securities | -- | BUY | 96.00 |
| 2026-07-30 | Goldman Sachs | -- | SELL | 70.00 |
| 2026-07-30 | RBC Capital | -- | HOLD | 85.00 |
| 2026-07-27 | RBC Capital | -- | HOLD | 85.00 |
| 2026-07-23 | Morgan Stanley | -- | BUY | 93.00 |
| 2026-07-21 | Barclays | -- | BUY | 120.00 |
| 2026-07-20 | Wells Fargo | -- | BUY | 93.00 |
| 2026-07-15 | Cantor Fitzgerald | -- | BUY | 130.00 |
| 2026-07-15 | BofA Securities | -- | BUY | 95.00 |
| 2026-07-13 | J.P. Morgan | -- | BUY | 91.00 |
| 2026-07-08 | Barclays | -- | BUY | 120.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
3 2
■ Upgrades■ Downgrades
- 3 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: Citi moved from Hold to Buy on 2026-06-09.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-09 | Citi | HOLD → BUY | 108.00 |
| 2026-05-27 | Jefferies | HOLD → BUY | 85.00 |
| 2026-05-08 | TD Cowen | HOLD → BUY | 90.00 |
| 2026-03-30 | Jefferies | BUY → HOLD | 76.00 |
| 2025-12-01 | RBC Capital | BUY → HOLD | 91.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-30 | After close | ±10.56% | -9.94% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±9.33% | +14.27% (beat) |
| 2025/Q4 | 2026-02-19 | After close | ±8.61% | +1.09% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±11.26% | +5.98% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±11.28% | -9.89% (in line) |
| 2025/Q1 | 2025-05-06 | After close | ±12.41% | +12.63% (beat) |
| 2024/Q4 | 2025-02-27 | After close | ±20.21% | +9.27% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±9.43% | +3.07% (in line) |
| 2024/Q2 | 2024-08-08 | After close | ±13.77% | -3.57% (in line) |
| 2024/Q1 | 2024-04-25 | After close | ±20.29% | +12.08% (in line) |
| 2023/Q4 | 2024-02-29 | After close | ±18.20% | +13.34% (in line) |
| 2023/Q3 | 2023-10-26 | After close | ±12.76% | -22.71% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:05:34 · For reference only, not investment advice and not tailored to your situation.